Imexhs (ASX:IME) — Material Events
ASX:IME · 11 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
IMEXHS Surpasses FY25 Targets with AI-Driven Radiology Platform ExpansionMedium
IMEXHS beats FY25 guidance with strong growth, advances AI-powered radiology platform, and sets positive FY26 outlook
20 May 2026
·Annual General Meeting Addresses
·85
IMEXHS Accelerates AI Radiology Platform with Strong Q1 Growth and Key Latin America DealsMedium
IMEXHS posts strong Q1 FY26 growth, advances AI radiology platform, secures key Latin American contracts
30 Apr 2026
·Quarterly Activity Report and Appendix 4C
·85
IMEXHS Surges with FY25 Revenue and EBITDA at Top Guidance LevelsMedium
IMEXHS FY25 Revenue and EBITDA at Top End of Guidance with Strong Q4 Software Growth and ARR Increase
30 Jan 2026
·Quarterly and Full Year Financial Results
·80
IMEXHS Surges to Profitability with 10% Revenue Growth in FY25Medium
IMEXHS FY25 revenue and EBITDA hit top guidance; strong ARR growth and positive outlook for FY26
27 Feb 2026
·Full Year Results
·80
IMEXHS Boosts Q3 Revenue and EBITDA, Eyes Software Growth Amid Colombia RisksMedium
IMEXHS Q3 FY25 revenue and EBITDA rise; reaffirmed FY25 guidance; new contracts and AI-driven cost savings boost margins
31 Oct 2025
·Quarterly Activity Report and Appendix 4C
·80
IMEXHS Faces $3M Loss Amid Goodwill Impairment but Boosts Recurring RevenueHigh
IMEXHS reports $3M half-year loss with $1.75M goodwill impairment, ARR up 11%, raises $2.6M capital
29 Aug 2025
·Appendix 4D Half-year report
·Unexpected
·75
IMEXHS Advances SaaS Growth Amid Margin Pressures in 1H FY25Medium
IMEXHS 1H FY25 Results Show Revenue Growth and Strategic Focus on SaaS Expansion and Margin Improvement
2 Sept 2025
·Investor Presentation
·75
IMEXHS Lands A$1.4M Contract to Boost Oncology Radiology in ColombiaMedium
IMEXHS Secures A$1.4M Radiology Services Contract with Colombian Cancer Care Provider Oncolife
26 Sept 2025
·Material Contract Announcement
·75
IMEXHS Grows ARR 11% as Aquila+ Platform Gains MomentumMedium
IMEXHS 1H FY25 revenue up 4%, ARR grows 11%, Aquila+ platform gains traction
29 Aug 2025
·Financial Results
·75
IMEXHS Boosts ARR 11% Amid Cost Cuts and Mexico Tender WinMedium
IMEXHS Q2 FY25 revenue stable; ARR up 11%, capital raise completed, cost cuts underway
31 July 2025
·Quarterly Activity Report and Appendix 4C
·70
IMEXHS Secures $384K ARR Mexico Tender for AI Radiology PlatformMedium
IMEXHS Wins $384K ARR Public Tender for AI Radiology Deployment in Mexico
25 May 2026
·Contract Win Announcement
·70
No articles in this tier for the last 12 months.
Market Mentions
6
- appeared in market wrap coverage
These are market wrap articles where Imexhs (ASX:IME) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Market Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026